SCHEMBL5724010

SCHEMBL5724010

OC[C@H](F)CN1CC=CCC1

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAOA P21397 6/20 0.38
MAOB P27338 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4495546 1.00 MAOA (0.38) MAOAMAOB
SCHEMBL4495541 0.81 MAOA (0.38) MAOAMAOB
SCHEMBL5724008 0.81 MAOA (0.38) MAOAMAOB
SCHEMBL27210001 0.72 MAOA (0.38) MAOAMAOB
SCHEMBL27230430 0.72 MAOA (0.38) MAOAMAOB
SCHEMBL67378 0.72
SCHEMBL7402418 0.71 MAOA (0.40) MAOAMAOB
SCHEMBL1099753 0.69
SCHEMBL5544187 0.68 MAOA (0.38) MAOAMAOB
SCHEMBL8991715 0.68 FDPS (0.36) MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003047582-A1 QUINOLINE DERIVATIVES AS ANTITUMOUR AGENTS ASTRAZENECA AB (SE) 2003-06-12 WO claimed
EP-1409481-B1 QUINOLINE DERIVATIVES AND THEIR USE AS TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2006-10-04 EP disclosed
WO-2003047582-A1 QUINOLINE DERIVATIVES AS ANTITUMOUR AGENTS ASTRAZENECA AB (SE) 2003-06-12 WO disclosed